Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 07, 2018 10:01 ET | Source: BioSenic

Bone Therapeutics collecte 19,45 M€ d'engagements dans le cadre d'un placement d'obligations convertibles

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Information réglementée - Information...
March 07, 2018 10:01 ET | Source: BioSenic

Bone Therapeutics Successfully Raises EUR 19.45 Million of Commitments in Convertible Bond Placement

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Regulated Information - Inside...
March 07, 2018 01:00 ET | Source: BioSenic

Bone Therapeutics annonce un placement privé sous forme d'obligations convertibles:

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Information réglementée - Information...
March 07, 2018 01:00 ET | Source: BioSenic

Bone Therapeutics Announces Private Placement of Convertible Bonds

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Regulated Information - Inside...
February 20, 2018 12:00 ET | Source: BioSenic

Bone Therapeutics SA annonce le renforcement de son Conseil d'administration avec la nomination de Jean Stéphenne en tant que Président

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Information réglementée Bone...
February 20, 2018 12:00 ET | Source: BioSenic

Bone Therapeutics SA strengthens Board with the appointment of Jean Stéphenne as Chairman

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Regulated information Bone...
February 19, 2018 01:00 ET | Source: BioSenic

Bone Therapeutics annonce le recrutement du dernier patient de son étude de Phase IIA dans la fusion vertébrale avec ALLOB®

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Communiqué de presse Bone...
February 19, 2018 01:00 ET | Source: BioSenic

Bone Therapeutics SA completes patient recruitment for Phase IIA Spinal Fusion study with ALLOB®

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Press release Bone Therapeutics...
January 23, 2018 01:00 ET | Source: BioSenic

Bone Therapeutics SA : Publie ses perspectives d'affaires et annonce son calendrier financier pour 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Information réglementée Bone...
January 23, 2018 01:00 ET | Source: BioSenic

Bone Therapeutics SA : Provides business outlook and announces its financial calendar for 2018

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Regulated information Bone Therapeutics...